Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$4.76B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.4B |
| 4 |
Amazon
AMZN
|
+$1.22B |
| 5 |
Broadcom
AVGO
|
+$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLTE
3751
Belite Bio
BLTE
$2.18B
| $314K | ﹤0.01% |
6,700
| – | – |
|
|
AUTL
3752
Autolus Therapeutics
AUTL
$367M
| $313K | ﹤0.01% |
86,256
| – | – |
|
|
HOOK
3753
DELISTED
HOOKIPA Pharma
HOOK
| $313K | ﹤0.01% |
72,679
+1,896
| +3% | +$8.16K |
|
3754
Reading International Class A
RDI
$35M
| $312K | ﹤0.01% |
191,237
-20,478
| -10% | -$33.4K |
|
|
GOOS
3755
Canada Goose Holdings
GOOS
$1.42B
| $312K | ﹤0.01% |
24,870
+386
| +2% | +$4.84K |
|
3756
Protara Therapeutics
TARA
$120M
| $311K | ﹤0.01% |
170,040
+29,514
| +21% | +$54K |
|
3757
Verde Clean Fuels
VGAS
$63.7M
| $310K | ﹤0.01% |
77,807
+6,191
| +9% | +$24.7K |
|
3758
Tempest Therapeutics
TPST
$46.7M
| $308K | ﹤0.01% |
16,928
+5,063
| +43% | +$92.2K |
|
|
OPRA
3759
Opera Ltd
OPRA
$1.76B
| $308K | ﹤0.01% |
19,937
| – | – |
|
3760
NextCure
NXTC
$14.7M
| $307K | ﹤0.01% |
18,645
+2,318
| +14% | +$38.1K |
|
3761
Bioceres Crop Solutions
BIOX
$124M
| $306K | ﹤0.01% |
38,927
| – | – |
|
3762
Chunghwa Telecom
CHT
$34.5B
| $305K | ﹤0.01% |
7,688
-5,929
| -44% | -$235K |
|
3763
Western Midstream Partners
WES
$14.6B
| $305K | ﹤0.01% |
7,959
+94
| +1% | +$3.6K |
|
3764
Ampco-Pittsburgh
AP
$54.7M
| $304K | ﹤0.01% |
152,111
+42,305
| +39% | +$84.6K |
|
3765
Fathom Holdings
FTHM
$66.7M
| $303K | ﹤0.01% |
116,816
+17,864
| +18% | +$46.3K |
|
3766
US Global Investors
GROW
$31.8M
| $301K | ﹤0.01% |
116,782
-2,529
| -2% | -$6.53K |
|
3767
Grupo Aeroportuario del Sureste
ASR
$10.1B
| $298K | ﹤0.01% |
1,054
-29
| -3% | -$8.2K |
|
3768
Nabors Energy Transition Corp II
NETD
| $298K | ﹤0.01% |
27,982
+9,557
| +52% | +$102K |
|
3769
Allied Gaming & Entertainment
AGAE
$33.6M
| $297K | ﹤0.01% |
216,856
+35,385
| +19% | +$48.5K |
|
|
GBNY
3770
DELISTED
Generations Bancorp NY, Inc. Common Stock
GBNY
| $297K | ﹤0.01% |
18,823
+7,555
| +67% | +$119K |
|
|
IMDX
3771
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$85.9M
| $296K | ﹤0.01% |
103,980
+11,289
| +12% | +$32.2K |
|
3772
Vor Biopharma
VOR
$228M
| $296K | ﹤0.01% |
422,143
-2,689
| -0.6% | -$1.88K |
|
3773
AbCellera Biologics
ABCL
$1.28B
| $295K | ﹤0.01% |
113,653
-201,213
| -64% | -$523K |
|
3774
CalciMedica
CALC
$48.8M
| $295K | ﹤0.01% |
66,553
+22,525
| +51% | +$99.8K |
|
3775
iPower
IPW
$16.7M
| $293K | ﹤0.01% |
161,924
-7,027
| -4% | -$12.7K |
|